🇺🇸 FDA
Patent

US 10208046

Nitrogen-containing heterocyclic compound

granted A61KA61K31/437A61K31/444

Quick answer

US patent 10208046 (Nitrogen-containing heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/4545, A61K31/501